Tepmetko (Tepotinib)
- Medicine Name: Tepmetko
- Generic Name: Tepotinib
- Dosage Form & Strength: Tablets: 225 mg
- Manufactured By: EMD Serono, Inc.
Tepmetko is a kinase inhibitor used for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC) harboring mesenchymal-epithelial transition (MET) exon 14 skipping alterations.
Recommended Dosage: The recommended dosage is 450 mg orally once daily with food until disease progression or unacceptable toxicity.Dose of Tepmetko tablet is taken at approximately the fixed time every day. Swallow the tablets whole. Do not chew, crush or split tablets. Do not to make up a missed dose within 8 hours of the next scheduled dose. In case vomiting occurs after taking a dose, patients should take the next dose at the scheduled time.
- ILD/pneumonitis, which can be fatal, occurred in patients treated with Tepmetko 225 mg tabets. Assess patients for new or worsening pulmonary signs/symptoms indicative of ILD/pneumonitis (e.g., cough, dyspnea, fever).
- Hepatotoxicity occurred in patients treated with Tepotinib. Monitor liver function tests (including AST, ALT, and total bilirubin) prior to the start of Tepotinib, every 2 weeks during the initial three months of treatment, then monthly, with a bit more frequent testing in those who develop enhanced transaminases or bilirubin.
- Depending on findings and its mechanism of action Tepmetko 225 mg can cause fetal harm if used by a pregnant woman. Females of reproductive age or males with female partners of reproductive age should use apt contraception during treatment and for 1-week after the last dose.
- Breastfeeding is restricted in women’s taking treatment with Tepotinib 225 mg. Women should not breastfeed during treatment and for 1-week after the last dose.
- Respective patients should inform their health specialist of all concomitant medicines, including prescription medications, over-the-counter drugs and herbal products.
What documents are required to import TEPMETKO to India?
TEPMETKO (tepotinib) tablets can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID Proof (issued by Government of India)
How does the order confirm?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor
- Import permit if applicable
Is TEPMETKO available in India?
TEPMETKO (tepotinib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
Urgent Meds helps import cancer medicines on the named patient supply (NPS). Urgent Meds is the facilitator providing input on the availability of Tepmetko in India (Hyderabad, Mumbai, Kolkata, Chennai, Ahmedabad, Delhi, Bangalore, and Pune etc.), medicine price, finding genuine and reliable sources from Canada, Europe, USA, and Australia, and ensuring 100% transparency.
TEPMETKO can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
Urgent Meds can facilitate the supply of TEPMETKO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +1-647-818-4196 or write to us at info@urgentmeds.in for Tepmetko tablets price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Urgent Meds is proficient in sourcing TEPMETKO (Cancer Treatment Medicines) from around the world and has the capability to supply it. We offer global access to the best available treatment for our customers worldwide.
Urgent Meds is committed to dispensing any valid prescription promptly. All prescriptions are dispensed and verified by registered pharmacists and are dispatched only to the patient’s address from New Delhi, India. Your health and well-being are our top priorities.
What is the Generic Name for the trade name drug Tepmetko®?
Tepotinib is the Generic Name for the trade name drug Tepmetko®.
Is Tepmetko® approved by the FDA?
Yes, Tepmetko® is approved by the FDA. Date of approval: February 3, 2021.
How is Tepmetko® typically administered?
Tepmetko (Tepotinib Tablets) is taken once daily with food. The tablet should be swallowed completely and never broken, opened, or chewed. Discuss with your health specialist for instructions in case you vomit or miss any dose.
What is the dosage and form of Tepmetko® supplied?
Tepmetko® is supplied as Tablets: 225 mg dosage strength for oral administration.
What are the most common side effects due to Tepmetko®?
The most common side effects due to Tepmetko® include nausea, edema, fatigue, diarrhea, musculoskeletal pain, and dyspnea.
How much does Tepmetko® cost in India?
Tepmetko cost in India is sensibly reasonable. In order to procure this NSCLC medication authentically, you can call or WhatsApp +1-647-818-4196 or send mail to info@urgentmeds.in.
What are the storage conditions of Tepmetko®?
Store the tablets at a temperature of 20°C to 25°C (68°F to 77°F); excursions are permitted to 15°C to 30°C (59°F to 86°F). Store in the original package.
Is it safe to buy Tepmetko® online in India?
Yes, in order to buy Tepotinib in India, always choose an absolutely legitimate, and WHO-GDP & ISO-certified Pharmaceutical Wholesaler/Distributor/Supplier.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.